HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors' Phenotypic Susceptibility. [PDF]
AIDS Res Hum RetrovirusesRodríguez-López ER +9 more
europepmc +1 more source
HIV drug resistance to integrase inhibitors in low- and middle-income countries. [PDF]
Nat MedFokam J +5 more
europepmc +1 more source
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysis. [PDF]
Oncol Res TreatYang J +5 more
europepmc +1 more source
Risk of viral failure after simplification therapy without using integrase inhibitors compared with maintenance of triple antiretroviral therapy: A systematic review and meta-analysis. [PDF]
Braz J Infect DisHelfer MS, Sprinz E.
europepmc +1 more source
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors. [PDF]
VirusesSun J, Kessl JJ.
europepmc +1 more source
Novel machine learning approach toward classification model of HIV-1 integrase inhibitors. [PDF]
RSC AdvPhan TL +6 more
europepmc +1 more source
A systematic review and meta-analysis of maternal weight changes and pregnancy outcomes associated with integrase inhibitors and tenofovir alafenamide in pregnant women with HIV. [PDF]
Am J Obstet Gynecol MFMEke AC +4 more
europepmc +1 more source
Recent Advances in the Development of Integrase Inhibitors for HIV Treatment. [PDF]
Curr HIV/AIDS Rep, 2020 Trivedi J +5 more
europepmc +1 more source
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors. [PDF]
Front ImmunolSaborido-Alconchel A +12 more
europepmc +1 more source